Trial
NCT00866723
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
Dana-Farber Cancer Institute; Massachusetts General Hospital; Genentech, Inc.
Condition
Ovarian Cancer
Intervention
bevacizumab
Why stopped
Recruitment has been terminated prematurely because of poor enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-22